These results provide evidence that CHEK2 down-regulation in breast stromal fibroblasts increases the paracrine pro-migration and -invasion of cancer cells, which further confirms the active status of CHEK2-deficient breast stromal fibroblasts. This evidence concerns the gene CHEK2 and cancer.